In Vitro Model at Centre of Antimicrobial Drug Development
The key to de-risking and expediting the development and approval of new antimicrobials is a…
WHAT’S NEW
Read our Nature Publication on Eliapixant, a Selective P2X3 Receptor Antagonist
Learn about our latest research on a selective P2X3 receptor antagonist for the treatment of…
Webinar: Robust and Comprehensive PK Prediction for Early Drug Discovery
Watch our webinar to learn about exciting new developments in pharmacokinetic prediction and how to…
Webinar: Metabolites in Safety Testing
Join us for an educational webinar on MIST strategy.
Transforming Toxicology Prediction using Panomics
Learn about transcriptomics and how the technology is transforming DILI and toxicology prediction.
WELCOME TO OUR COMMUNITY
Want updates about our latest scientific research, news and insights from Evotec, Cyprotex, and Just – Evotec Biologics? Join our Community to receive new content as it is released on the Science Pool.
Latest Blogs
Latest News
Evotec and Almirall enter into a multi-target alliance in medical dermatology
- May 18, 2022
Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a 'functional cure' for diabetes
- May 16, 2022